Urinary phytoestrogen concentrations in the U.S. population (1999-2000)

Journal of Exposure Analysis and Environmental Epidemiology

Volumn 15, Issue 6, 2005, Pages 509-523

  Valentín Blasini, Liza ^a   Sadowski, Melissa A ^a   Walden, Donna ^a   Caltabiano, Lisa ^a   Needham, Larry L ^a   Barr, Dana B ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Daidzein; General population; Genistein; Isoflavones; Lignans; Phytoestrogens; Urine

Indexed keywords

CREATININE; DAIDZEIN; ENTERODIOL; ENTEROLACTONE; EQUOL; GENISTEIN; ISOFLAVONE; LIGNAN; PHYTOESTROGEN;

ADOLESCENT; ADULT; ARTICLE; CANCER; CONTROLLED STUDY; DEMOGRAPHY; DIETARY INTAKE; ESTROGEN URINE LEVEL; ETHNOLOGY; FEMALE; GEOMETRY; HEART PROTECTION; HISPANIC; HUMAN; MALE; POPULATION; RACE DIFFERENCE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; UNITED STATES; URINALYSIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILD; FEMALE; HUMANS; MALE; PHYTOESTROGENS; POPULATION SURVEILLANCE; UNITED STATES;

EID: 27844483459     PISSN: 10534245     EISSN: 14765519     Source Type: Journal    
DOI: 10.1038/sj.jea.7500429     Document Type: Article

References (79)

1. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995: 103(Suppl. 7): 103-112.
2. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002: 3: 364-373.
3. Adlercreutz H., Fotsis T., Bannwart C., Wahala K., Makela T., Brunow G., and Hase T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986: 25: 791-797.
4. Adlercreutz H., Fotsis T., Kurzer M.S., Wahala K., Makela T., and Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Anal Biochem 1995a: 225: 101-108.
5. Adlercreutz H., Fotsis T., Watanabe S., Lampe J., Wahala K., Makela T., and Hase T. Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prev 1994: 18: 259-271.
6. Adlercreutz H., Hamalainen E., Gorbach S., and Goldin B. Dietary phytooestrogens and the menopause in Japan. Lancet 1992: 339: 1233.
7. Adlercreutz H., Hockerstedt K., Bannwart C., Bloigu S., Hamalainen E., Fotsis T., and Ollus A. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987: 27: 1135-1144.
8. Adlercreutz H., Honjo H., Higashi A., Fotsis T., Hamalainen E., Hasegawa T., and Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991: 54: 1093-1100.
9. Adlercreutz H., and Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997: 29: 95-120.
10. Adlercreutz H., van der W.J., Kinzel J., Attalla H., Wahala K., Makela T., Hase T., and Fotsis T. Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 1995b: 52: 97-103.
11. Adlercreutz H., Yamada T., Wahala K., and Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol 1999: 180: 737-743.
12. Albertazzi P., Pansini F., Bottazzi M., Bonaccorsi G., De Aloysio D., and Morton M.S. Dietary soy supplementation and phytoestrogen levels. Obstet Gynecol 1999: 94(2): 229-231.
13. Anderson J.J., Anthony M.S., Cline J.M., Washburn S.A., and Garner S.C. Health potential of soy isoflavones for menopausal women. Public Health Nutr 1999: 2: 489-504.
14. Anderson J.W., Johnstone B.M., and Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995: 333: 276-282.
15. Arai Y., Uehara M., Sato Y., Kimira M., Eboshida A., Adlercreutz H., and Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 2000: 10: 127-135.
16. Bannwart C., Fotsis T., Heikkinen R., and Adlercreutz H. Identification of the isoflavonic phytoestrogen daidzein in human urine. Clln Chim Acta 1984: 136(1-2): 165-172.
17. Barnes S., Grubbs C., Setchell K.D., and Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza M.W., Aeschbacher H.W., Elton J.S., Sato S. (eds.) Mutagens and Carcinogens in the Diet. Wiley-Liss: New York, 1990, pp. 239-253.
18. Bennetau-Pelissero C., Le Houerou C., Lamothe V., Le Menn F., Babin P., and Bennetau B. Synthesis of haptens and conjugates for ELISAs of phytoestrogens. Development of the immunological tests. J Agric Food Chem 2000: 48: 305-311.
19. Bernert Jr. J.T., Turner W.E., Pirkle J.L., Sosnoff C.S., Akins J.R., Waldrep M.K., Ann Q., Covey T.R., Whitfield W.E., Gunter E.W., Miller B.B., Patterson Jr. D.G., Needham L.L., Hannon W.H., and Sampson E.J. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997: 43: 2281-2291.
20. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002: 76: 1191-1201.
21. Cassidy A., and Griffin B. Phyto-oestrogens: a potential role in the prevention of CHD? Proc Nutr Soc 1999: 58: 193-199.
22. Centers for Disease Control and Prevention. Second National Report on Human Exposure to Environmental Chemicals, 2003. Available at www.cdc.gov/exposurereport.
23. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Available: www.cdc.gov/nchs/nhanes.htm.
24. Clarkson T.B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002: 132: 566S-569S.
25. Clarkson T.B., and Anthony M.S. Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab 1998: 12: 589-604.
26. Coward L., Smith M., Kirk M., and Barnes S. Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 1998: 68: 1486S-1491S.
27. Dai Q., Franke A.A., Jin F., Shu X.O., Hebert J.R., Custer L.J., Cheng J., Gao Y.T., and Zheng W. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002: 11: 815-821.
28. Davis S.R., Dalais F.S., Simpson E.R., and Murkies A.L. Phytoestrogens in health and disease. Recent Prog Horm Res 1999: 54: 185-210.
29. Day A.J., DuPont M.S., Ridley S., Rhodes M., Rhodes M.J., Morgan M.R., and Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett 1998: 436: 71-75.
30. de Kleijn M.J., van der Schouw Y.T., Wilson P.W., Grobbee D.E., and Jacques P.F. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr 2002: 132: 276-282.
31. den Tonkelaar I., Keinan-Boker L., Veer P.V., Arts C.J., Adlercreutz H., Thijssen J.H., and Peeters P.H. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001: 10: 223-228.
32. Foster W.G., Chan S., Platt L., and Hughes Jr. C.L. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 2002: 129: 199-205.
33. Franke A.A., and Custer L.J. High performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B Biomed Appl 1994: 662(1): 47-60.
34. Franke A.A., Custer L.J., Cerna C.M., and Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 1995: 208: 18-26.
35. Franke A.A., Yu M.C., Maskarinec G., Fanti P., Zheng W., and Custer L.J. Phytoestrogens in human biomatrices including breast milk. Biochem Soc Trans. 1999: 27: 308-318.
36. Gambacciani M., Ciaponi M., Cappagli B., Piaggesi L., and Genazzani A.R. Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women. Maturitas 1997: 28: 75-81.
37. Gooderham M.H., Adlercreutz H., Ojala S.T., Wahala K., and Holub B.J. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 1996: 126: 2000-2006.
38. Horn-Ross P.L., Barnes S., Kirk M., Coward L., Parsonnet J., and Hiatt R.A. Urinary phytoestrogen levels in young women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 1997: 6: 339-345.
39. Hornung R.W., and Reed D.L. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990: 5: 46-51.
40. Hutchins A.M., Lampe J.W., Martini M.C., Campbell D.R., and Slavin J.L. Vegetables, fruits, and legumes: effect on urinary isoflavonoid phytoestrogen and lignan excretion. J Am Diet Assoc 1995a: 95: 769-774.
41. Hutchins A.M., Slavin J.L., and Lampe J.W. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 1995b: 95: 545-551.
42. Ingram D., Sanders K., Kolybaba M., and Lopez D. Case-control study of phytooestrogens and breast cancer. Lancet 1997: 350: 990-994.
43. Irvine C.H., Fitzpatrick M.G., and Alexander S.L. Phytoestrogens in soy-based infant foods: concentrations, daily intake, and possible biological effects. Proc Soc Exp Biol Med 1998: 217: 247-253.
44. Joannou G.E., Kelly G.E., Reeder A.Y., Waring M., and Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biocliem Mol Biol 1995: 54: 167-184.
45. Kardinaal A.F., Morton M.S., Bruggemann-Rotgans I.E., and van Beresteijn E.C. Phyto-oestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr 1998: 52(11): 850-855.
46. Karr S.C., Lampe J.W., Hutchins A.M., and Slavin J.L. Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 1997: 66: 46-51.
47. Kelly G.E., Joannou G.E., Reeder A.Y., Nelson C., and Waring M.A. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 1995: 208: 40-43.
48. Kim M.K., Chung B.C., Yu V.Y., Nam J.H., Lee H.C., Huh K.B., and Lim S.K. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women. Clin Endocrinol (Oxf) 2002: 56: 321-328.
49. Kirkman L.M., Lampe J.W., Campbell D.R., Martini M.C., and Slavin J. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr Cancer 1995: 24(1): 1-12.
50. Kurzer M.S. Hormonal effects of soy in premenopausal women and men. J Nutr 2002: 132: 570S-573S.
51. L'homme R., Brouwers E., Al Maharik N., Lapcik O., Hampl R., Mikola H., Wahala K., and Adlercreutz H. Time-resolved fluoroimmunoassay of plasma and urine O-desmethylangolensin. J Steroid Biochem Mol Biol 2002: 81: 353-361.
52. Lampe J.W. Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 2003: 133: 956S-964S.
53. Lampe J.W., Gustafson D.R., Hutchins A.M., Martini M.C., Li S., Wahala K., Grandits G.A., Potter J.D., and Slavin J.L. Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake. Biomarkers Prev 1999: 8: 699-707.
54. Lampe J.W., Karr S.C., Hutchins A.M., and Slavin J.L. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998: 217: 335-339.
55. Maubach J., Bracke M.E., Heyerick A., Depypere H.T., Serreyn R.F., Mareel M.M., and De Keukeleire D. Quantitation of soy-derived phytoestrogens in human brease tissue and biological fluids by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2003: 784: 137-144.
56. Messina M., and Bennink M. Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Bailliers Clin Endocrinol Metab 1998: 12: 707-728.
57. Morton M.S., Arisaka O., Miyake N., Morgan L.D., and Evans B.A. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002: 132: 3168-3171.
58. Murphy P.A., Song T., Buseman G., Barua K., Beecher G.R., Trainer D., and Holden J. Isoflavones in retail and institutional soy foods. J Agric Food Chem 1999: 47: 2697-2704.
59. Reinli K, and Block G. Phytoestrogen content foods - a compendium of literature values. Nutr Cancer 1996: 26: 123-148.
60. Roach V.J., Cheung T.F., Chung T.K., Hjelm N.M., Waring M.A., Loong E.P., and Haines C.J. Phytoestrogens: dietary intake and excretion in postmenopausal Chinese women. Climacteric 1998: 1: 290-295.
61. Rowland I., Wiseman H., Sanders T., Adlercreutz H., and Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 1999: 27: 304-308.
62. Rowland I.R., Wiseman H., Sanders T.A., Adlercreutz H., and Bowey E.A. Interindividual variation in metabolism of soy isoflavones and ligans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000: 36: 27-32.
63. Serraino M., and Thompson L.U. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett 1991: 60: 135-142.
64. Serraino M., and Thompson L.U. Flaxseed supplementation and eary markers of colon carconogenesis. Cancer Lett 1992: 63: 159-165.
65. Setchell K.D., Borriello S.P., Hulme P., Kirk D.N., and Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984: 40: 569-578.
66. Setchell K.D., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T., Kirschner A.S., Cassidy A., and Heubi J.E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001: 131: 1362S-1375S.
67. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002a: 132: 3577-3584.
68. Setchell K.D., Brown N.M., Zimmer-Nechemias L., Brashear W.T., Wolfe B.E., Kirschner A.S., and Heubi J.E. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002b: 76: 447-453.
69. Setchell K.D., and Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999: 129: 758S-767S.
70. Setchell K.D., Faughnan M.S., Avades T., Zimmer-Nechemias L., Brown N.M., Wolfe B.E., Brashear W.T., Desai P., Oldfield M.F., Botting N.P., and Cassidy A. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 2003: 77: 411-419.
71. Severson R.K., Nomura A.M., Grove J.S., and Stemmermann G.N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989: 49: 1857-1860.
72. Stumpf K., Pietinen P., Puska P., and Adlercreutz H. Changes in serum enterolactone, genistein, and daidzein in a dietary intervention study in Finland. Cancer Epidemiol Biomarkers Prev 2000: 9: 1369-1372.
73. Thompson L.U., Robb P., Serraino M., and Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991: 16: 43-52.
74. Uehar M., Arai Y., Watanabe S., and Adlercreutz H. Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Biofactors 2000: 12: 217-225.
75. Valentín-Blasini L., Blount B.C., Caudill S.P., and Needham L.L. Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 2003: 13: 276-282.
76. Valentín-Blasini L., Blount B.C., Rogers H.S., and Needham L.L. HPLC-MS/MS method for the measurement of seven phytoestrogens in human serum and urine. J Expo Anal Environ Epidemiol 2000: 10: 799-807.
77. Vincent A., and Fitzpatrick L.A. Soy isoflavones: are they useful in menopause? Mayo Clin Proc 2000: 75: 1174-1184.
78. Xu X., Duncan A.M., Merz B.E., and Kurzer M.S. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998: 7(12): 1101-1108.
79. Zhang Y., Wang G.J., Song T.T., Murphy P.A., and Hendrich S. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity. J Nutr 1999: 129: 957-962.